Abstract
Background/objectives:
High intake of added sweeteners is considered to have a causal role in the pathogenesis of cardiometabolic disorders. Especially, high-fructose intake is regarded as potentially harmful to cardiometabolic health. It may cause not only weight gain but also low-grade inflammation, which represents an independent risk factor for developing type 2 diabetes and cardiovascular disease. In particular, fructose has been suggested to induce plasminogen activator inhibitor-1 (PAI-1) expression in the liver and to increase circulating inflammatory cytokines. We therefore aimed to investigate, whether high-fructose diet has an impact on PAI-1, monocyte chemoattractant protein-1 (MCP-1), e-selectin and C-reactive protein (CRP) concentrations in healthy humans.
Subjects/methods:
We studied 20 participants (12 males and 8 females) of the TUebingen FRuctose Or Glucose study. This is an exploratory, parallel, prospective, randomized, single-blinded, outpatient, hypercaloric, intervention study. The participants had a mean age of 30.9±2.1 years and a mean body mass index of 26.0±0.5 kg/m2 and they received 150 g of either fructose or glucose per day for 4 weeks.
Results:
There were neither significant changes of PAI-1, MCP-1, e-selectin and CRP after fructose (n=10) and glucose (n=10) intervention nor treatment effects (all P>0.2). Moreover, we did not observe longitudinal associations of the inflammatory parameters with triglycerides, liver fat, visceral fat and body weight in the fructose group.
Conclusions:
Temporary high-fructose intake does not seem to cause inflammation in apparently healthy people in this secondary analysis of a small feeding trial.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH et al. American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism and the Council on Epidemiology and Prevention. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009; 120: 1011–1020.
Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004; 292: 927–934.
Hajer GR, van Haeften TW, Visseren FL . Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29: 2959–2971.
Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med 2011; 365: 1876–1885.
Schmidt M, Johannesdottir SA, Lemeshow S, Lash TL, Ulrichsen SP, Bøtker HE et al. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. BMJ Open 2013; 3: e002698.
Tappy L, Lê KA . Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010; 90: 23–46.
Lustig RH, Schmidt LA, Brindis CD . Public health: The toxic truth about sugar. Nature 2012; 482: 27–29.
Bray GA . Fructose and risk of cardiometabolic disease. Curr Atheroscler Rep 2012; 14: 570–578.
Rippe JM, Angelopoulos TJ . Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know? Adv Nutr 2013; 4: 236–245.
White JS . Challenging the fructose hypothesis: new perspectives on fructose consumption and metabolism. Adv Nutr 2013; 4: 246–256.
Ha V, Jayalath VH, Cozma AI, Mirrahimi A, de Souza RJ, Sievenpiper JL . Fructose-containing sugars, blood pressure, and cardiometabolic risk: a critical review. Curr Hypertens Rep 2013; 15: 281–297.
Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I . Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. Lab Invest 2011; 91: 885–895.
Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008; 138: 1452–1455.
Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC et al. Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. J Clin Endocrinol Metab 2011; 96: E2034–E2038.
Aeberli I, Gerber PA, Hochuli M, Kohler S, Haile SR, Gouni-Berthold I et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr 2011; 94: 479–485.
Brymora A, Flisiński M, Johnson RJ, Goszka G, Stefańska A, Manitius J . Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant 2012; 27: 608–612.
Thorand B, Löwel H, Schneider A, Kolb H, Meisinger C, Fröhlich M et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med 2003; 163: 93–99.
Emerging Risk Factors Collaboration,, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132–140.
Silbernagel G, Machann J, Unmuth S, Schick F, Stefan N, Häring HU et al. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr 2011; 106: 79–86.
Silbernagel G, Kovarova M, Cegan A, Machann J, Schick F, Lehmann R et al. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet. J Clin Endocrinol Metab 2012; 97: E2288–E2292.
Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, Claussen CD et al. Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 2005; 21: 455–462.
Machann J, Thamer C, Schnoedt B, Stefan N, Haring HU, Claussen CD et al. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 2006; 55: 913–917.
Stanhope KL, Schwarz JM, Havel PJ . Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies. Curr Opin Lipidol 2013; 24: 198–206.
Tappy L, Mittendorfer B . Fructose toxicity: is the science ready for public health actions? Curr Opin Clin Nutr Metab Care 2012; 15: 357–361.
Marriott BP, Olsho L, Hadden L, Connor P . Intake of added sugars and selected nutrients in the United States, National Health and Nutrition Examination Survey (NHANES) 2003-2006. Crit Rev Food Sci Nutr 2010; 50: 228–258.
Acknowledgements
We thank Anna Bury, Barbara Horrer, Ellen Kollmar, Andreas Vosseler and Heike Runge for expert technical assistance. The study was supported by a grant (Grant no. 4 AI) from the Zentrum Ernährungsmedizin Tübingen-Hohenheim. Funding did not include industrial sponsorship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
GS received a research grant from Unilever, Rotterdam, the Netherlands. The remaining authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Silbernagel, G., Machann, J., Häring, HU. et al. Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets. Eur J Clin Nutr 68, 97–100 (2014). https://doi.org/10.1038/ejcn.2013.228
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2013.228
Keywords
This article is cited by
-
Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis
Diabetologia (2018)
-
Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues
Scientific Reports (2016)
-
Fructose induces prothrombotic phenotype in human endothelial cells
Journal of Thrombosis and Thrombolysis (2015)